Skip to content

Schizophrenia for Life - a Registry and Interview Study Among Elderly With Lifelong Schizophrenia

Schizophrenia for Life - a Registry and Interview Study Among Elderly With Lifelong Schizophrenia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02246283
Enrollment
10404
Registered
2014-09-22
Start date
2013-09-30
Completion date
2017-12-31
Last updated
2018-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Keywords

schizophrenia, elderly, lifelong, quality of life, register, questionaire

Brief summary

The elderly demographic is on the rise - and this includes elderly living with schizophrenia. Yet very little is known about their lives, how they cope with their condition and how it develops over time. Research in this patient-group is sparse; overall there seem to be a tendency for elderly patients to manifest fewer psychotic symptoms and experiencing an increase in the psychological quality of life with older age. Opinions are divided on the degree and extent to which this tendency reflects remission and/or recovery in older patients. In order to identify factors associated with a positive outcome we: * Investigate the course and the outcomes of the illness over the lifespan, as well as the life course and outcomes. * Investigate the current status of mental and physical health, quality of life as well as functional competence of elderly (55+ yr) with schizophrenia. Also the investigators \- Compare the trajectory and prognosis of schizophrenia (a chronic mental illness) with type 1 diabetes (a chronic somatic illness). This study will yield vital insights into how schizophrenia develops over time, isolating factors that determine how well patients fare. The perspective is to advance knowledge of elderly with schizophrenia with a view to optimizing and increasing the effectiveness of the interventions offered to this group.

Interventions

None listed

Sponsors

Kjeld Andersen
Lead SponsorOTHER
The Psychiatric Research Foundation in Southern Denmark
CollaboratorUNKNOWN
Region of Southern Denmark
CollaboratorOTHER
University of Southern Denmark
CollaboratorOTHER
The Danish Mental Health Foundation
CollaboratorOTHER
The Danish Health Foundation (Helsefonden)
CollaboratorUNKNOWN
The non-profit foundation Trygfonden.
CollaboratorUNKNOWN
Odense Patient Data Explorative Network
CollaboratorOTHER
Jeppe Juhl and Ovita Juhls Memorial Grant
CollaboratorUNKNOWN
Butcher Max Wørzner and wife Inger Wørzner's Memorial Grant
CollaboratorUNKNOWN

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
55 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

Initial schizophrenia diagnosis between the ages 18-40 (both incl) in the period 1970-1979 (both incl) Interview study: Residence in Region of Southern Denmark

Exclusion criteria

Interview study: Mental retardation \-

Design outcomes

Primary

MeasureTime frameDescription
Ageing with schizophreniaup to 45 yearsPrognosis measured by use of healthcare system, use of medicine, co-morbidity, mortality, causes of mortality, and socio-demographic data, including highest level of education, years of employment/un-employment, use of health- and welfare services.

Secondary

MeasureTime frameDescription
Quality of life1 monthQuestionnaire
Remission6 monthsQuestionnaire

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026